In idiopathic pulmonary fibrosis (IPF) patients, serum MMP7 levels were higher at baseline (pre‐treatment) and at 1 year of antifibrotic treatment in those with progressive disease, compared to those with stable disease. This evidence concerns the gene MMP7 and pulmonary fibrosis.